Literature DB >> 24506164

Social anxiety disorder, a lifelong disorder? A review of the spontaneous remission and its predictors.

N Vriends1, O C Bolt, S M Kunz.   

Abstract

OBJECTIVE: Based on clinical observations, social anxiety disorder (SAD) is usually described as a chronic disorder. Its natural course in the community is less clear.
METHOD: The present review summarises prospective and retrospective spontaneous remission rates of SAD in the community and its predictors that were published after 1987. Remission rates were specified as partial, defined as still having social fears, but not fulfilling the diagnostic criteria, and full, defined as having no social fears anymore.
RESULTS: In prospective studies, remission rates of SAD varied between 36% and 93% and in retrospective studies between 3% and 80%. The estimated average remission rate in prospective studies was 50% for full remission and 79% when including partial remission. In retrospective studies, the average remission rate was 26% during the last year and 56% over the lifetime. Diverse predictors of remission of SAD have been found that can be clustered into less severe anxiety, less additional psychopathology, less stress, employment, and mental health.
CONCLUSION: The enormous variation in remission rates indicates that SAD might have different course types (short, fluctuating, and chronic) and is not necessarily a chronic disorder. Prevention and treatment should be focused on enhancing positive and reducing negative factors.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  epidemiology; review of the literature; risk factors; social phobia

Mesh:

Year:  2014        PMID: 24506164     DOI: 10.1111/acps.12249

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

1.  Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder.

Authors:  Nur Hani Zainal; William W Chan; Alisha P Saxena; Craig Barr Taylor; Michelle G Newman
Journal:  Behav Res Ther       Date:  2021-10-06

2.  Parsing differences in amygdala volume among individuals with and without social and generalized anxiety disorders across the lifespan.

Authors:  Jennifer H Suor; Jagan Jimmy; Christopher S Monk; K Luan Phan; Katie L Burkhouse
Journal:  J Psychiatr Res       Date:  2020-05-30       Impact factor: 4.791

3.  Evaluating a Web-Based Social Anxiety Intervention Among Community Users: Analysis of Real-World Data.

Authors:  Hugh Cameron McCall; Fjola Dogg Helgadottir; Ross G Menzies; Heather D Hadjistavropoulos; Frances S Chen
Journal:  J Med Internet Res       Date:  2019-01-10       Impact factor: 5.428

4.  Long-term administration of escitalopram in patients with social anxiety disorder in Japan.

Authors:  Satoshi Asakura; Taiji Hayano; Atsushi Hagino; Tsukasa Koyama
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-22       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.